Short Interest in TC Biopharm (Holdings) Plc (NASDAQ:TCBP) Decreases By 41.0%

TC Biopharm (Holdings) Plc (NASDAQ:TCBP) was the target of a large decrease in short interest in the month of November. As of November 15th, there was short interest totalling 38,300 shares, a decrease of 41.0% from the October 31st total of 64,900 shares. Based on an average daily volume of 1,230,000 shares, the days-to-cover ratio is currently 0.0 days.

TC Biopharm Stock Performance

Shares of NASDAQ TCBP traded down $0.04 during mid-day trading on Thursday, hitting $0.60. The company had a trading volume of 588,937 shares, compared to its average volume of 507,867. TC Biopharm has a 12 month low of $0.56 and a 12 month high of $91.20. The company has a current ratio of 0.88, a quick ratio of 0.88 and a debt-to-equity ratio of 1.31. The firm’s 50 day simple moving average is $3.16 and its two-hundred day simple moving average is $6.25.

TC Biopharm Company Profile

TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on the development of immunotherapy products based on its allogeneic gamma delta T cell platform. Its product pipeline includes OmnImmune, an allogeneic unmodified gamma-delta T cell therapy product under Phase 2/3 trails for the treatment of acute myeloid leukemia; and ImmuniStim, an unmodified cell therapy to treat viral infections as well as cancers.